GCIEX | VIVIX | GCIEX / VIVIX | |
Total Expense Ratio | 1.18 | 0.04 | 2,950% |
Annual Report Gross Expense Ratio | 1.18 | 0.04 | 2,950% |
Fund Existence | 18 years | 27 years | - |
Gain YTD | 12.901 | 7.897 | 163% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 50000 | 5000000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 465M | 196B | 0% |
Annual Yield % from dividends | 12.87 | 2.19 | 589% |
Returns for 1 year | -1.31 | 7.01 | -19% |
Returns for 3 years | -2.61 | 32.61 | -8% |
Returns for 5 years | -8.51 | 68.64 | -12% |
Returns for 10 years | -46.26 | 129.59 | -36% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBMC | 103.69 | 0.62 | +0.60% |
JPMorgan BetaBuilders US Mid Cap Eq ETF | |||
PTH | 40.06 | 0.21 | +0.52% |
Invesco Dorsey Wright Healthcare MomtETF | |||
TBFG | 28.44 | N/A | N/A |
The Brinsmere Fund - Growth ETF | |||
ETH | 43.01 | -0.30 | -0.69% |
Grayscale Ethereum Mini Trust ETF | |||
BOUT | 37.80 | -0.46 | -1.20% |
Innovator IBD® Breakout Opps ETF |